Shelley Perry If you’re a first-time ScaleUp CEO—or it’s been a while since you’ve looked at M&A—here’s the 2026 update:
If you’re not AI-native, AI-native alternatives in your space are already pressuring your valuation multiple.
And that changes how you should think about M&A.
Because in 2026, you can buy revenue and still end up worth less.
I recently walked a founder through this mental model, because it’s easy to get excited about an M&A opportunity and miss what actually drives value in an exit or a major funding round.
Quick definition:
When I say enterprise value, I mean what a buyer or Growth Equity investor is really underwriting: durability, defensibility, and a believable path to scale. Valuation is the headline. Enterprise value is what supports it.
The new normal: AI is a multiple issue, not a feature issue
Here’s what’s different now.
In prior cycles, you could buy revenue and expect the market to reward the growth.
In 2026, investors are asking:
“Is this business becoming AI-defensible—or are we underwriting a category that AI will commoditize?”
Customers may still be buying. But investors are pricing the risk now. That shows up as:
- lower multiples
- heavier diligence
- less patience for “we’ll add AI” roadmaps
- and a bigger penalty for revenue that looks fragile in an AI-shaped future
And sometimes it shows up even more bluntly: no interest at all. In 2026, AI uncertainty doesn’t just compress multiples—it can make a deal feel not underwrite able, which shows up as lower offers… or a hard pass.
The 2026 M&A trap: more revenue can compress your multiple
In the past, M&A was a proven way to increase enterprise value and valuation, the conversation usually goes: “Revenue goes up, valuation goes up.”
Today, in the ScaleUp state, also considered Growth Equity underwriting, it can work like this:
Revenue goes up + AI uncertainty goes up = multiple goes down, check size changes
You have now lost the opportunity to have a smaller up and coming growth equity firm write a check, as you are too big, and the check size for larger growth equity + risk.
That’s how “more revenue” may hurt you more than you know.
Revenue that looks good—but can hurt valuation in 2026
Here’s the kind of revenue investors discount faster (especially when AI-native alternatives exist):
- Rented distribution revenue (SEO, aggregators, partner feeds you don’t control)
- Low-margin revenue that drags blended gross margin down
- Services-heavy revenue that scales with headcount
- Cyclical revenue that disappears when budgets tighten
- Revenue with weak retention or unclear renewal dynamics
- Revenue that adds complexity but not defensibility
None of this means “don’t buy it.”
It means don’t assume it raises valuation.
What works now: “Better together” + AI-defensible
In 2026, M&A is valuation-positive when the combined company becomes:
- harder to displace (especially by AI-native workflows)
- more embedded in customer workflow
- more defensible through data, trust, switching costs, or distribution
- more scalable with operating leverage
- more underwriteable for Growth Equity and strategic buyers
In other words: better together, ai-defensible not just bigger.
Three questions to ask before you fall in love with the deal
If you keep one section, keep this one.
1) Does this deal make us AI-defensible—or just bigger?
If it doesn’t reduce AI risk, be careful about assuming multiple expansion. The only exception being that the scale / revenue / profit gives you the room you need to also become ai-definsable before a major transaction.
2) What moat do we have after we acquire it?
Not “what do we get.” What do we own, what is our moat?
- distribution
- workflow position
- switching costs
- trust/data advantage
- exclusive supply/relationships
3) What’s the mechanism that increases enterprise value?
Synergy isn’t a spreadsheet number. It’s a mechanism:
- AI-definsible
- reduces churn
- improves pricing power
- lowers CAC in a provable way
- improves margin / cost-to-serve
- creates expansion customers actually want
If you can’t explain the mechanism clearly, you don’t have a deal thesis—you have a hope.
A simple ScaleUp M&A scorecard (fast)
Rate each 1–5 vs your baseline business.
- AI-defensibility: does it reduce AI risk or accelerate your AI-native trajectory?
- Moat: switching costs, workflow embed, trust/data, owned distribution
- Durability: renewal + expansion visibility
- Economics: gross margin + cost-to-serve trajectory
- Integration: time-to-value, complexity, leadership bandwidth
If it doesn’t improve your baseline, don’t assume it improves valuation.
Bottom line
ScaleUp Stage M&A in 2026 isn’t about buying revenue.
It’s about creating enterprise value—and becoming AI-defensible before you plan a major funding round or exit.
Because yes: in this market, more revenue can make you worth less if it increases uncertainty faster than it increases defensibility.
